130
Views
6
CrossRef citations to date
0
Altmetric
Review

Role of trastuzumab in the management of HER2-positive metastatic breast cancer

, , , &
Pages 93-109 | Published online: 24 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Giovanna Chilà, Vincenzo Guarini, Danilo Galizia, Elena Geuna & Filippo Montemurro. (2021) The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Drug Design, Development and Therapy 15, pages 2711-2720.
Read now
Rania Shamekh, Marilin Rosa, Zena Sayegh, Masoumeh Ghayouri, Richard Kim, Mokenge P Malafa & Domenico Coppola. (2017) Expression of Her-2/neu in extrahepatic cholangiocarcinoma. Pathology and Laboratory Medicine International 9, pages 9-14.
Read now

Articles from other publishers (4)

Sneh Lata Gupta, Naeem Khan, Srijani Basu & Vijay Soni. (2022) B-Cell-Based Immunotherapy: A Promising New Alternative. Vaccines 10:6, pages 879.
Crossref
莲莲 项. (2021) Research Progress of the Treatment of Combined Traditional Chinese and Western Medicine on Cardiotoxicity of Breast Cancer Patients Caused by Trastuzumab. Traditional Chinese Medicine 10:04, pages 511-515.
Crossref
Xiao-Xiao Wu, Grace Gar-Lee Yue, Jin-Run Dong, Christopher Wai-Kei Lam, Chun-Kwok Wong, Ming-Hua Qiu & Clara Bik-San Lau. (2020) Actein Inhibits Tumor Growth and Metastasis in HER2-Positive Breast Tumor Bearing Mice via Suppressing AKT/mTOR and Ras/Raf/MAPK Signaling Pathways. Frontiers in Oncology 10.
Crossref
Yanyuan Wu, Marianna Sarkissyan & Jaydutt V. Vadgama. 2015. Cancer Epigenetics. Cancer Epigenetics 425 466 .